Nucleases have gained attention in cancer therapy, especially in the field of gene editing. Tools like CRISPR-Cas9 utilize nucleases to introduce targeted genetic modifications. This technology holds promise for treating genetic mutations linked to cancer. Additionally, certain nucleases are being explored for their ability to induce cell death specifically in cancer cells, sparing normal cells.
